An NCI-designated Comprehensive Cancer Center
LA Mag feature image
Forging ahead despite advanced mesothelioma
August 7, 2020 | by Abe Rosenberg
A dire cancer diagnosis of Stage 3 mesothelioma — during a national pandemic — sparks a blacksmith’s 1,200-mile journey to City of Hope to join a potentially lifesaving clinical trial. His doctor? One of his former knife-making students, Yuman Fong, M.D., chair of the Department of Surgery.
Patient Care
Breakthroughs - leukemia 2016 - 256x256
Not all mutations lead to cancer, study finds
August 6, 2020 | by Letisia Marquez
City of Hope scientists find that genetic mutations must develop in a certain order to progress to cancer. Certain mutations may actually thwart that progression. Based on that research, new drug combinations aim to intercept cancer development.
breakthroughs - stomach cancer 7 risk factors
Study probes alarming increase of GI cancers in young Hispanics
August 5, 2020 | by Maxine Nunes
Doctors are seeing a dramatic rise in gastrointestinal cancers in young adults, especially among Hispanics. New research by City of Hope's Yanghee Woo, M.D., who has treated many such patients, looks at what common factors might be involved.
Tabithas Story thumb | City of Hope
Young mom prevails against stage 4 lung cancer
July 29, 2020 | by Abe Rosenberg
Tabitha Paccione was a 35-year-old nonsmoker when she was diagnosed with advanced lung cancer after almost a year of misdiagnoses. Luckily, she found City of Hope's Ravi Salgia, M.D., Ph.D., who identified her rare cancer type and put her on a unique treatment regimen. She is now in remission.
lung cancer | Patient Care
A genetic test may predict your susceptibility to COVID
July 28, 2020 | by Maxine Nunes
HLA typing — a simple genetic procedure used in bone marrow transplants — might help determine who is most at risk for contracting COVID-19, who might have the worst response and how the most effective vaccine can be developed.
Patient Care | COVID-19
Kidney Cancer
A personalized roadmap
to treat kidney cancer
July 24, 2020 | by Zen Vuong
Physician-scientists at City of Hope and TGen are using one of the world’s most comprehensive genomic analysis tools to determine whether targeted therapy or immunotherapy has the best chance of working for each individual patient.
Patient Care | Research